Both in Pharmaceuticals
Onconetix vs KALA BIO
Over the past year ONCO returned −99.6% and KALA returned −99.5%; their daily moves had a correlation of -0.02.
ONCO −99.6% KALA −99.5%Growth of $1, one year, split-adjusted
| Metric | ONCO | KALA |
|---|---|---|
| Price | $0.6237 | $0.1793 |
| Market cap | $3.7M | $3.5M |
| Today | +9.61% | +3.64% |
| 1 month | −5.7% | −50.7% |
| 6 months | −86.1% | −96.9% |
| Year to date | −99.2% | −99.4% |
| 1 year | −99.6% | −99.5% |
| Revenue growth (YoY) | −83.9% | — |
| Gross margin | 25.1% | — |
| Net margin | −16748.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.7× | — |
| Net cash | $5.8M | $7.2M |
| Dividend yield | — | — |
| Volatility (60d) | 157.9% | 120.5% |
| Short % of float | 7.4% | 3.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).